e-learning
resources
Glasgow 2004
Wednesday 08.09.2004
Systemic and metabolic effects from OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association between obstructive sleep apnea hypopnea and metabolic syndromes
X. Zhang, K. Yin, H. Mao (Nanjing, China)
Source:
Annual Congress 2004 - Systemic and metabolic effects from OSA
Session:
Systemic and metabolic effects from OSA
Session type:
Oral Presentation
Number:
4233
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. Zhang, K. Yin, H. Mao (Nanjing, China). Association between obstructive sleep apnea hypopnea and metabolic syndromes. Eur Respir J 2004; 24: Suppl. 48, 4233
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
Association between daytime hypersomnolence and the metabolic syndrome in men with obstructive sleep apnea
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Prevalence of complex sleep apnea among German patients with obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Socioeconomic status and obstructive sleep apnea hypopnea syndrome (OSAHS)
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Cost estimation of obstructive sleep apnea hypopnea syndrome (OSAHS) diagnosis in Greece
Source: Annual Congress 2010 - Influence of delivery of care on outcome parameters: therapy is more than medication prescription
Year: 2010
Oxygen for the treatment of obstructive sleep apnoea hypopnoea syndrome
Source: Breathe, 15 (3) e104; 10.1183/20734735.0206-2019
Year: 2019
Resources and delays in the diagnosis of sleep apnea and hypopnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 329s
Year: 2007
Comorbidities of obstructive sleep apnoea syndrome
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
Gender difference on EEG arousal in patients with obstructive sleep apnea hypopnea syndrome
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008
Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Association of obstructive sleep apnea hypopnea syndrome with cardiovascular disease: a candidate gene association study
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Diagnosis of sleep-related breathing disorders and definition of hypopnoea and obstructive sleep apnoea severity
Source: International Congress 2018 – PG7 Sleep-disordered breathing - diagnosis and therapy
Year: 2018
Evaluation of the effect of inspirational muscle training in patients with apnea and hypopnea sleep obstructive syndrom
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017
Change in PLMS after treatment of obstructive sleep apnea
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
Masked hypertension and obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 416s
Year: 2006
Clinical assessment of obstructive sleep apnoea
Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts
Year: 2006
What is the impact of obstructive sleep apnea hypopnea syndrome and daytime sleepiness on work performance?
Source: International Congress 2017 – Variation in th phenotypes and symptoms of obstructive sleep apnoea
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept